Measurement of RNA levels and expression as well as protein expression in multiple tumor types has revealed that OSMR is overexpressed in some synovial sarcoma tumors and that the expression level is abundant enough for targeted therapy (Figure 1). This evidence concerns the gene OSMR and neoplasm.